Table 2.
Fracture events of patients who completed the 18-months study duration
| Study period of TPTD administration | −18 ~ −13 months | −12 ~ −7 months | −6 ~ 0 months | 0 ~ 6 months | 7 ~ 12 months | 13 ~ 18 months |
|---|---|---|---|---|---|---|
| Patients | 0 | 1 | 6 | 0 | 0 | 1 |
| Fracture events | 0 | 1 | 7 | 0 | 0 | 1 |
This table shows the number of total fracture events and patients with new fractures before or after TPTD administration